Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man

Authors

  • T. LUNDÅSEN,

    Search for more papers by this author
    • *

      These authors contributed equally to this work.

  • C. GÄLMAN,

    Search for more papers by this author
    • *

      These authors contributed equally to this work.

  • B ANGELIN,

    1. From the Metabolism Unit, Department of Endocrinology, Metabolism & Diabetes, Department of Medicine, and Molecular Nutrition Unit, Center for Nutrition and Toxicology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Search for more papers by this author
  • M. RUDLING

    1. From the Metabolism Unit, Department of Endocrinology, Metabolism & Diabetes, Department of Medicine, and Molecular Nutrition Unit, Center for Nutrition and Toxicology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Search for more papers by this author

Errata

This article is corrected by:

  1. Errata: Erratum Volume 263, Issue 4, 459, Article first published online: 6 March 2008

Abstract.

Bile acids (BAs) traversing the enterohepatic circulation exert several important metabolic effects. Their hepatic synthesis, controlled by the enzyme cholesterol 7α-hydroxylase (CYP7A1), has a unique diurnal variation in man. Here we provide evidence that the transintestinal flux of BAs regulates serum levels of intestinal fibroblast growth factor 19 (FGF19) that in turn modulate BA production in human liver. Basal FGF19 levels varied by 10-fold in normal subjects, and were reduced following treatment with a BA-binding resin and increased upon feeding the BA chenodeoxycholic acid. Serum FGF19 levels exhibited a pronounced diurnal rhythm with peaks occurring 90–120 min after the postprandial rise in serum BAs. The FGF19 peaks in turn preceded the declining phase of BA synthesis. The diurnal rhythm of serum FGF19 was abolished upon fasting. We conclude that, in humans, circulating FGF19 has a diurnal rhythm controlled by the transintestinal BA flux, and that FGF19 modulates hepatic BA synthesis. Through its systemic effects, circulating FGF19 may also mediate other known BA-dependent effects on lipid and carbohydrate metabolism.

Ancillary